BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Levine A, Turner D, Pfeffer Gik T, Amil Dias J, Veres G, Shaoul R, Staiano A, Escher J, Kolho KL, Paerregaard A, Martin de Carpi J, Veereman Wauters G, Koletzko S, Shevah O, Finnby L, Sladek M. Comparison of outcomes parameters for induction of remission in new onset pediatric Crohn's disease: evaluation of the porto IBD group "growth relapse and outcomes with therapy" (GROWTH CD) study. Inflamm Bowel Dis 2014;20:278-85. [PMID: 24390062 DOI: 10.1097/01.MIB.0000437735.11953.68] [Cited by in Crossref: 53] [Cited by in F6Publishing: 21] [Article Influence: 7.6] [Reference Citation Analysis]
Number Citing Articles
1 Ban Q, Liu M, Ding N, Chen Y, Lin Q, Zha J, He W. Nutraceuticals for the Treatment of IBD: Current Progress and Future Directions. Front Nutr 2022;9:794169. [DOI: 10.3389/fnut.2022.794169] [Reference Citation Analysis]
2 Ashton JJ, Green Z, Young A, Borca F, Coelho T, Batra A, Afzal NA, Ennis S, Johnson MJ, Beattie RM. Growth failure is rare in a contemporary cohort of paediatric inflammatory bowel disease patients. Acta Paediatr 2021;110:326-34. [PMID: 32485032 DOI: 10.1111/apa.15383] [Reference Citation Analysis]
3 Narula N, Dhillon A, Zhang D, Sherlock ME, Tondeur M, Zachos M. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2018;4:CD000542. [PMID: 29607496 DOI: 10.1002/14651858.CD000542.pub3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 40] [Article Influence: 9.0] [Reference Citation Analysis]
4 Gong D, Yu X, Wang L, Kong L, Gong X, Dong Q. Exclusive Enteral Nutrition Induces Remission in Pediatric Crohn's Disease via Modulation of the Gut Microbiota. Biomed Res Int 2017;2017:8102589. [PMID: 29124070 DOI: 10.1155/2017/8102589] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
5 Mitchel EB, Rosh JR. Pediatric Management of Crohn’s Disease. Gastroenterology Clinics of North America 2022. [DOI: 10.1016/j.gtc.2021.12.013] [Reference Citation Analysis]
6 Herrador-López M, Martín-Masot R, Navas-López VM. EEN Yesterday and Today … CDED Today and Tomorrow. Nutrients 2020;12:E3793. [PMID: 33322060 DOI: 10.3390/nu12123793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Sáez-González E, Mateos B, López-Muñoz P, Iborra M, Moret I, Nos P, Beltrán B. Bases for the Adequate Development of Nutritional Recommendations for Patients with Inflammatory Bowel Disease.Nutrients. 2019;11:1062. [PMID: 31083616 DOI: 10.3390/nu11051062] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
8 Ruemmele FM, Hyams JS, Otley A, Griffiths A, Kolho KL, Dias JA, Levine A, Escher JC, Taminiau J, Veres G, Colombel JF, Vermeire S, Wilson DC, Turner D. Outcome measures for clinical trials in paediatric IBD: an evidence-based, expert-driven practical statement paper of the paediatric ECCO committee. Gut 2015;64:438-46. [PMID: 24821616 DOI: 10.1136/gutjnl-2014-307008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 7.6] [Reference Citation Analysis]
9 Levine A, Sigall Boneh R, Wine E. Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases. Gut 2018;67:1726-38. [PMID: 29777041 DOI: 10.1136/gutjnl-2017-315866] [Cited by in Crossref: 143] [Cited by in F6Publishing: 116] [Article Influence: 35.8] [Reference Citation Analysis]
10 MacLellan A, Moore-Connors J, Grant S, Cahill L, Langille MGI, Van Limbergen J. The Impact of Exclusive Enteral Nutrition (EEN) on the Gut Microbiome in Crohn's Disease: A Review. Nutrients 2017;9:E0447. [PMID: 28468301 DOI: 10.3390/nu9050447] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 7.4] [Reference Citation Analysis]
11 Van Limbergen J, Haskett J, Griffiths AM, Critch J, Huynh H, Ahmed N, deBruyn JC, Issenman R, El-Matary W, Walters TD, Kluthe C, Roy ME, Sheppard E, Crandall WV, Cohen S, Ruemmele FM, Levine A, Otley AR. Toward enteral nutrition for the treatment of pediatric Crohn disease in Canada: a workshop to identify barriers and enablers. Can J Gastroenterol Hepatol 2015;29:351-6. [PMID: 26076398 DOI: 10.1155/2015/509497] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
12 Matuszczyk M, Kierkus J. Nutritional Therapy in Pediatric Crohn's Disease-Are We Going to Change the Guidelines? J Clin Med 2021;10:3027. [PMID: 34300192 DOI: 10.3390/jcm10143027] [Reference Citation Analysis]
13 Swaminath A, Feathers A, Ananthakrishnan AN, Falzon L, Li Ferry S. Systematic review with meta-analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease. Aliment Pharmacol Ther 2017;46:645-56. [PMID: 28815649 DOI: 10.1111/apt.14253] [Cited by in Crossref: 57] [Cited by in F6Publishing: 43] [Article Influence: 11.4] [Reference Citation Analysis]
14 Martín-de-Carpi J, Jiménez Treviño S, Pujol Muncunill G, Martín-Masot R, Navas-López VM. [Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis]. An Pediatr (Engl Ed) 2020;92:242.e1-9. [PMID: 31883747 DOI: 10.1016/j.anpedi.2019.11.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Sahu P, Kedia S, Ahuja V, Tandon RK. Diet and nutrition in the management of inflammatory bowel disease. Indian J Gastroenterol 2021;40:253-64. [PMID: 34037954 DOI: 10.1007/s12664-021-01163-x] [Reference Citation Analysis]
16 Scarallo L, Lionetti P. Dietary Management in Pediatric Patients with Crohn's Disease. Nutrients 2021;13:1611. [PMID: 34064976 DOI: 10.3390/nu13051611] [Reference Citation Analysis]
17 Logan M, Clark CM, Ijaz UZ, Gervais L, Duncan H, Garrick V, Curtis L, Buchanan E, Cardigan T, Armstrong L, Delahunty C, Flynn DM, Barclay AR, Tayler R, McDonald E, Milling S, Hansen RK, Gerasimidis K, Russell RK. The reduction of faecal calprotectin during exclusive enteral nutrition is lost rapidly after food re-introduction. Aliment Pharmacol Ther 2019;50:664-74. [PMID: 31342536 DOI: 10.1111/apt.15425] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
18 Buderus S, Scholz D, Behrens R, Classen M, De Laffolie J, Keller KM, Zimmer KP, Koletzko S; CEDATA-GPGE Study Group. Inflammatory bowel disease in pediatric patients: Characteristics of newly diagnosed patients from the CEDATA-GPGE Registry. Dtsch Arztebl Int 2015;112:121-7. [PMID: 25759978 DOI: 10.3238/arztebl.2015.0121] [Cited by in Crossref: 4] [Cited by in F6Publishing: 24] [Article Influence: 0.7] [Reference Citation Analysis]
19 Navas-lópez VM, Pujol-muncunill G, Llerena E, Navalón Rubio M, Gil-ortega D, Varea-calderón V, Sierra Salinas C, Martin-de-carpi J. A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease. Anales de Pediatría (English Edition) 2018;88:89-99. [DOI: 10.1016/j.anpede.2017.03.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Armstrong H, Alipour M, Valcheva R, Bording-Jorgensen M, Jovel J, Zaidi D, Shah P, Lou Y, Ebeling C, Mason AL, Lafleur D, Jerasi J, Wong GK, Madsen K, Carroll MW, Huynh HQ, Dieleman LA, Wine E. Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseases. Microbiome 2019;7:1. [PMID: 30606251 DOI: 10.1186/s40168-018-0604-3] [Cited by in Crossref: 56] [Cited by in F6Publishing: 28] [Article Influence: 18.7] [Reference Citation Analysis]
21 Ashton JJ, Mossotto E, Ennis S, Beattie RM. Personalising medicine in inflammatory bowel disease-current and future perspectives. Transl Pediatr 2019;8:56-69. [PMID: 30881899 DOI: 10.21037/tp.2018.12.03] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
22 Connors J, Basseri S, Grant A, Giffin N, Mahdi G, Noble A, Rashid M, Otley A, Van Limbergen J. Exclusive Enteral Nutrition Therapy in Paediatric Crohn's Disease Results in Long-term Avoidance of Corticosteroids: Results of a Propensity-score Matched Cohort Analysis. J Crohns Colitis 2017;11:1063-70. [PMID: 28575325 DOI: 10.1093/ecco-jcc/jjx060] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 8.5] [Reference Citation Analysis]
23 Storck LJ, Imoberdorf R, Ballmer PE. Nutrition in Gastrointestinal Disease: Liver, Pancreatic, and Inflammatory Bowel Disease. J Clin Med 2019;8:E1098. [PMID: 31349549 DOI: 10.3390/jcm8081098] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
24 Shaoul R, Day AS. An Overview of Tools to Score Severity in Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:615216. [PMID: 33912519 DOI: 10.3389/fped.2021.615216] [Reference Citation Analysis]
25 Damas OM, Garces L, Abreu MT. Diet as Adjunctive Treatment for Inflammatory Bowel Disease: Review and Update of the Latest Literature. Curr Treat Options Gastroenterol. 2019;17:313-325. [PMID: 30968340 DOI: 10.1007/s11938-019-00231-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
26 Martín-de-carpi J, Treviño SJ, Muncunill GP, Martín-masot R, Navas-lópez VM. Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis. Anales de Pediatría (English Edition) 2020;92:242.e1-9. [DOI: 10.1016/j.anpede.2019.11.004] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Yu Y, Chen KC, Chen J. Exclusive enteral nutrition versus corticosteroids for treatment of pediatric Crohn's disease: a meta-analysis. World J Pediatr. 2019;15:26-36. [PMID: 30666565 DOI: 10.1007/s12519-018-0204-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
28 Tang W, Hu W, Shi P, Ye Z, Wu J, Zhang Y, Wang Y, Huang Y. The SES-CD Could Be a Predictor of Short- and Long-Term Mucosal Healing After Exclusive Enteral Nutrition in Pediatric Crohn’s Disease Patients. Front Pediatr 2022;10:874425. [DOI: 10.3389/fped.2022.874425] [Reference Citation Analysis]
29 Hradsky O, Copova I, Zarubova K, Nevoral J, Bronsky J. Time to Relapse in Children with Crohn's Disease Treated with Azathioprine and Nutritional Therapy or Corticosteroids. Dig Dis Sci 2016;61:2041-50. [PMID: 26971092 DOI: 10.1007/s10620-016-4103-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Church PC, Greer MC, Cytter-Kuint R, Doria AS, Griffiths AM, Turner D, Walters TD, Feldman BM. Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease. Pediatr Radiol 2017;47:565-75. [PMID: 28283726 DOI: 10.1007/s00247-017-3790-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
31 Burgess D, McGrath KH, Watson C, Collins T, Brown S, Marks K, Dehlsen K, Herbison K, Landorf E, Benn L, Fox J, Liew M. Exclusive enteral nutrition: An optimal care pathway for use in children with active luminal Crohn's disease. J Paediatr Child Health 2022. [PMID: 35181966 DOI: 10.1111/jpc.15911] [Reference Citation Analysis]